                         SEQUENCE LISTING

<110>  Zealand Pharma A/S
       Boehringer Ingelheim International GmbH
 
<120>  Acylated glucagon analogue

<130>  GRF/FP7192412

<150>  EP 15163903.6
<151>  2015-04-16

<160>  5     

<170>  PatentIn version 3.3

<210>  1
<211>  29
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic compound

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Aib

<220>
<221>  SITE
<222>  (28)..(28)
<223>  Lys([17-Carboxy-heptadecanoyl]-isoGlu-GSGSGG)

<400>  1

His Ala Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Glu 
1               5                   10                  15      


Arg Ala Ala Lys Asp Phe Ile Glu Trp Leu Glu Lys Ala 
            20                  25                  


<210>  2
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic hexapeptide spacer

<400>  2

Gly Ser Gly Ser Gly Gly 
1               5       


<210>  3
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  3

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr 
            20                  25                  


<210>  4
<211>  8
<212>  PRT
<213>  Homo sapiens

<400>  4

Lys Arg Asn Arg Asn Asn Ile Ala 
1               5               


<210>  5
<211>  37
<212>  PRT
<213>  Homo sapiens

<400>  5

His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser 
1               5                   10                  15      


Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr Lys Arg Asn 
            20                  25                  30          


Arg Asn Asn Ile Ala 
        35          


